Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Biovaxys Technology Corp (BVAXF)
Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BVAXF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0300 +136.67%
on 02/02/24
0.0750 -5.33%
on 02/21/24
+0.0360 (+102.86%)
since 01/26/24
3-Month
0.0091 +680.22%
on 12/08/23
0.0750 -5.33%
on 02/21/24
+0.0300 (+73.17%)
since 11/24/23
52-Week
0.0091 +680.22%
on 12/08/23
0.0752 -5.59%
on 03/01/23
-0.0011 (-1.53%)
since 02/24/23

Most Recent Stories

More News
Annual Financial Statements Update for the Year Ended October 31, 2023

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in the completion of...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the acquisition of the...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
HRZN : 13.03 (+0.31%)
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive Asset Purchase...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
HRZN : 13.03 (+0.31%)
BIOVAXYS ANNOUNCES COMPLETION OF FINAL TRANCHE OF PRIVATE PLACEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the final tranche of a...

BVAXF : 0.0710 (+7.25%)
BIOV.CN : 0.1000 (+17.65%)
BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a...

BVAXF : 0.0710 (+7.25%)
BIOV.CN : 0.1000 (+17.65%)
BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it completed the settlement of...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it intends to complete a non-brokered...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
BioVaxys Executes Letter of Intent for Major Immunotherapeutics Technology Acquisition

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that it has executed a non-binding Letter of...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)
BioVaxys and Procare Health Agree to Termination of USA Distribution Agreement for Papilocare

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that as part of BioVaxys' efforts to refocus...

BIOV.CN : 0.1000 (+17.65%)
BVAXF : 0.0710 (+7.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.0759
2nd Resistance Point 0.0722
1st Resistance Point 0.0692
Last Price 0.0710
1st Support Level 0.0625
2nd Support Level 0.0588
3rd Support Level 0.0558

See More

52-Week High 0.0752
Last Price 0.0710
Fibonacci 61.8% 0.0499
Fibonacci 50% 0.0421
Fibonacci 38.2% 0.0344
52-Week Low 0.0091

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar